Literature DB >> 1610064

Otolaryngologic manifestations of the mucopolysaccharidoses.

J K Bredenkamp1, M E Smith, J P Dudley, J C Williams, R L Crumley, D M Crockett.   

Abstract

A retrospective review of 45 children with mucopolysaccharidoses was performed to determine the frequency of complications related to the head and neck. In this series, every patient had at least one complication involving the head and neck region, and in over half, operative intervention by the otolaryngologist was required. Upper airway obstruction occurred in 17 (38%) and necessitated a tracheostomy in 7 (16%). Cervical spine instability occurred in 8 (18%), making airway management difficult. Recurrent respiratory infections occurred in 17 (38%), and chronic recurrent middle ear effusions were noted in 33 (73%). This review demonstrates that children afflicted with the mucopolysaccharidoses frequently have otolaryngologic-related complications that are common throughout their life span and often the primary management issue in their continuing care. The otolaryngologic management of these patients is outlined based on the results of this study and review of the relevant literature.

Entities:  

Mesh:

Year:  1992        PMID: 1610064     DOI: 10.1177/000348949210100605

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  13 in total

Review 1.  Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA.

Authors:  Christian J Hendriksz; Maisoon Al-Jawad; Kenneth I Berger; Sara M Hawley; Rebecca Lawrence; Ciarán Mc Ardle; C Gail Summers; Elizabeth Wright; Elizabeth Braunlin
Journal:  J Inherit Metab Dis       Date:  2012-02-23       Impact factor: 4.982

Review 2.  International guidelines for the management and treatment of Morquio A syndrome.

Authors:  Christian J Hendriksz; Kenneth I Berger; Roberto Giugliani; Paul Harmatz; Christoph Kampmann; William G Mackenzie; Julian Raiman; Martha Solano Villarreal; Ravi Savarirayan
Journal:  Am J Med Genet A       Date:  2014-10-24       Impact factor: 2.802

Review 3.  ENT and mucopolysaccharidoses.

Authors:  Pier Marco Bianchi; Renato Gaini; Silvano Vitale
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

4.  Audiometric evaluation in individuals with mucopolysaccharidosis.

Authors:  Marcela Rosana Maia da Silveira; Ana Karina Lima Buriti; Ana Maria Martins; Daniela Gil; Marisa Frasson de Azevedo
Journal:  Clinics (Sao Paulo)       Date:  2018-12-03       Impact factor: 2.365

5.  Laryngeal, Tracheal, and Bronchial Disease in the Mucopolysaccharidoses: Endoscopic Study.

Authors:  Paulo Pires de Mello; Anneliese Lopes Barth; Danielle de Araujo Torres; Mariana Pires de Mello Valente; Dafne Dain Gandelman Horovitz
Journal:  Diagnostics (Basel)       Date:  2020-01-10

6.  Otolaryngologists and the Early Diagnosis of Mucopolysaccharidoses: A Cross-Sectional Study.

Authors:  Danielle de Araujo Torres; Anneliese Lopes Barth; Mariana Pires de Mello Valente; Paulo Pires de Mello; Dafne Dain Gandelman Horovitz
Journal:  Diagnostics (Basel)       Date:  2019-11-13

7.  Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B.

Authors:  Coy D Heldermon; Anne K Hennig; Kevin K Ohlemiller; Judith M Ogilvie; Erik D Herzog; Annalisa Breidenbach; Carole Vogler; David F Wozniak; Mark S Sands
Journal:  PLoS One       Date:  2007-08-22       Impact factor: 3.240

8.  Management of otolaryngological manifestations in mucopolysaccharidoses: our experience.

Authors:  M Mesolella; M Cimmino; E Cantone; A Marino; M Cozzolino; R Della Casa; G Parenti; M Iengo
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-08       Impact factor: 2.124

9.  Disease correction by combined neonatal intracranial AAV and systemic lentiviral gene therapy in Sanfilippo Syndrome type B mice.

Authors:  C D Heldermon; E Y Qin; K K Ohlemiller; E D Herzog; J R Brown; C Vogler; W Hou; J L Orrock; B E Crawford; M S Sands
Journal:  Gene Ther       Date:  2013-03-28       Impact factor: 5.250

10.  Mediastinal Tracheostoma for Treatment of Tracheostenosis after Tracheostomy in a Patient with Mucopolysaccharidosis-Induced Tracheomalacia.

Authors:  Yasuhiro Chikaishi; Kenichi Kobayashi; Shuichi Shinohara; Akihiro Taira; Yusuke Nabe; Shinji Shinohara; Taiji Kuwata; Masaru Takenaka; Soichi Oka; Ayako Hirai; Kazue Yoneda; Koji Kuroda; Naoko Imanishi; Yoshinobu Ichiki; Fumihiro Tanaka
Journal:  Case Rep Surg       Date:  2017-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.